Despite the neuroprotective potential of RSV as a SIRT1 activator and PARP1 inhibitor, the low oral bioavailability of this polyphenol has limited its use as an effective drug to treat neurodegenerative diseases [43]. This evidence concerns the gene SIRT1 and neurodegenerative disease.